ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 1206

$516K Total Retail Price of All Prescriptions

Rank: 151 out of 1206

488 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 488 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,247 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 558 513 1 1
LEVOTHYROXINE SODIUM 541 505 2 2
FUROSEMIDE 452 408 3 5
OMEPRAZOLE 424 404 4 3
HYDROCODONE-ACETAMINOPHEN 321 240 S3 5 7
LISINOPRIL 317 307 6 4
AMLODIPINE BESYLATE 300 284 7 6
POTASSIUM CHLORIDE 240 215 8 12
TRAMADOL HCL 217 184 9 17
CITALOPRAM HBR 203 191 10 16
METOPROLOL SUCCINATE 200 188 11 15
METFORMIN HCL 193 155 12 10
WARFARIN SODIUM 188 176 13 8
HYDROCHLOROTHIAZIDE 186 174 14 11
ATORVASTATIN CALCIUM 184 183 15 13
GABAPENTIN 177 136 16 18
METOPROLOL TARTRATE 173 150 17 9
DONEPEZIL HCL 172 172 18 29
PAROXETINE HCL 165 160 19 53
ALENDRONATE SODIUM 164 163 20 19
LOSARTAN POTASSIUM 149 133 21 20
ZOLPIDEM TARTRATE 142 130 22 25
SERTRALINE HCL 131 125 23 22
GLIMEPIRIDE 123 112 24 34
ATENOLOL 123 108 24 14
CRESTOR 122 82 26 30
RISPERIDONE 107 94 27 74
NAMENDA 97 97 28 36
FENTANYL 93 81 S2 29 51
PRAVASTATIN SODIUM 91 91 30 21
LOSARTAN-HYDROCHLOROTHIAZIDE 91 87 30 60
TRAZODONE HCL 89 87 32 37
LANTUS 77 72 33 38
RANITIDINE HCL 76 44 34 23
MELOXICAM 75 62 35 35
AMLODIPINE BESYLATE-BENAZEPRIL 75 56 35 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 69 37 27
TRIAMTERENE-HCTZ 72 69 38 33
LANTUS SOLOSTAR 68 68 39 85
PREDNISONE 65 65 40 28
FLUTICASONE PROPIONATE 65 58 40 42
SOTALOL 65 65 40 177
POLYETHYLENE GLYCOL 3350 64 62 43 31
CIPROFLOXACIN HCL 58 54 44 61
QUETIAPINE FUMARATE 57 57 45 79
JANTOVEN 54 54 46 95
CARBIDOPA-LEVODOPA 54 54 46 70
NEXIUM 54 43 46 47
BENAZEPRIL HCL 53 46 49 39
NOVOLOG 51 49 50 100
CARVEDILOL 50 50 51 32
OXYCODONE HCL 50 25 S2 51 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.